Abstract
Coronavirus disease 2019 (COVID-19) vaccination campaign in Italy has started with a huge perplexity about vaccine efficacy, vaccine-borne adverse effects and vaccine clinical trial studies. In this commentary I tried to elucidate these issues, which represent a fundamental topic to be thoroughly addressed in COVID-19 pandemic.
Keywords:
administrative law; coronavirus; political science; public policy; social science; virus classification.
© 2021 Wiley Periodicals LLC.
MeSH terms
-
2019-nCoV Vaccine mRNA-1273
-
Anaphylaxis / etiology
-
BNT162 Vaccine
-
COVID-19 / epidemiology
-
COVID-19 / immunology
-
COVID-19 / prevention & control*
-
COVID-19 Vaccines* / adverse effects
-
COVID-19 Vaccines* / immunology
-
Health Knowledge, Attitudes, Practice
-
Humans
-
Italy / epidemiology
-
Liposomes / adverse effects
-
Mass Vaccination
-
Nanoparticles / adverse effects
-
Pandemics / prevention & control
-
Polyethylene Glycols / adverse effects
-
Vaccination Refusal*
-
Vaccines, Synthetic* / adverse effects
-
Vaccines, Synthetic* / immunology
-
mRNA Vaccines
Substances
-
COVID-19 Vaccines
-
Lipid Nanoparticles
-
Liposomes
-
Vaccines, Synthetic
-
Polyethylene Glycols
-
2019-nCoV Vaccine mRNA-1273
-
BNT162 Vaccine